Towards robust immune responses after heterologous COVID-19 vaccination and its application perspectives

Towards robust immune responses after heterologous COVID-19 vaccination and its application perspectives

Bibliographic Details
Main Authors:	Lin Yong, Huang Ailong
Format:	Article
Language:	English
Published:	Science Press 2022-03-01
Series:	National Science Open
Online Access:	https://www.sciengine.com/doi/10.1360/nso/20220008

Similar Items

Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice
by: Spencer, AJ, et al.
Published: (2021)

Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice
by: Alexandra J. Spencer, et al.
Published: (2021-05-01)

Unravelling the enhanced vaccine immunity by heterologous KCONVAC/Ad5-nCoV COVID-19 vaccination
by: Weijun Zhao, et al.
Published: (2022-07-01)

Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines.
by: Tamara Elliott, et al.
Published: (2022-10-01)

Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates
by: Qian He, et al.
Published: (2021-01-01)

Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine
by: Thuy Trang Nguyen, et al.
Published: (2022-03-01)

Heterologous immunity induced by 1st generation COVID-19 vaccines and its role in developing a pan-coronavirus vaccine
by: Raj S. Patel, et al.
Published: (2022-08-01)

Heterologous immune responses in health and disease
by: A. P. Toptygina
Published: (2020-05-01)

Editorial: Heterologous Immunity: Implications and Applications in Vaccines and Immunotherapies
by: Shakti Singh, et al.
Published: (2020-07-01)

Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice.
by: Kirsi Tamminen, et al.
Published: (2013-01-01)

Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial
by: Liu, X, et al.
Published: (2023)

Heterologous ChAdOx1-BNT162b2 vaccination in Korean cohort induces robust immune and antibody responses that includes Omicron
by: Hye Kyung Lee, et al.
Published: (2022-06-01)

Virus-Induced T Cell-Mediated Heterologous Immunity and Vaccine Development
by: Kathrin Balz, et al.
Published: (2020-03-01)

Heterologous Immunity: Role in Natural and Vaccine-Induced Resistance to Infections
by: Babita Agrawal
Published: (2019-11-01)

Heterologous vaccine interventions: boosting immunity against future pandemics
by: Daniela Marín-Hernández, et al.
Published: (2021-05-01)

Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine
by: Jialu Zhang, et al.
Published: (2021-01-01)

Heterologous COVID-19 Vaccination and Booster with mRNA Vaccine Provide Enhanced Immune Response in Patients with Cirrhosis: A Prospective Observational Study
by: Pimsiri Sripongpun, et al.
Published: (2023-09-01)

Durable natural killer cell responses after heterologous two-dose Ebola vaccination
by: Helen R. Wagstaffe, et al.
Published: (2021-01-01)

Heterologous Covid-19 vaccines intervention effect on reactogenicity
by: Wajeha Najeeb, et al.
Published: (2023-12-01)

Heterologous COVID-19 vaccination in pregnant women: Comment
by: Pathum Sookaromdee, et al.
Published: (2023-08-01)

Immune responses following 3rd and 4th doses of heterologous and homologous COVID-19 vaccines in kidney transplant recipients
by: Tina Thomson, et al.
Published: (2022-11-01)

Investigation of Adverse Events Experienced by Healthcare Workers following Immunization with Homologous or Heterologous COVID-19 Booster Vaccinations
by: Yunhua Wei, et al.
Published: (2022-11-01)

Homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: Comment
by: Rujitika Mungmunpuntipantip, et al.
Published: (2023-08-01)

Cross-Reactive Effects of Vaccines: Heterologous Immunity between Tetanus and Chlamydia
by: Marijana Stojanovic, et al.
Published: (2020-12-01)

Roles of the Fc Receptor γ-Chain in Inducing Protective Immune Responses after Heterologous Vaccination against Respiratory Syncytial Virus Infection
by: Hye Suk Hwang, et al.
Published: (2021-03-01)

The Effects of Heterologous Immunization with Prime-Boost COVID-19 Vaccination against SARS-CoV-2
by: Tzu-Chuan Ho, et al.
Published: (2021-10-01)

Heterologous Immunization With Defined RNA and Subunit Vaccines Enhances T Cell Responses That Protect Against Leishmania donovani
by: Malcolm S. Duthie, et al.
Published: (2018-10-01)

Influence of Heterologous and Homologous Vaccines, and Their Components, on the Host Immune Response and Protection Against Experimental Caprine Paratuberculosis
by: Noive Arteche-Villasol, et al.
Published: (2022-01-01)

Immune response of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA COVID-19 vaccines in immunocompromised patients
by: Chang Chu, et al.
Published: (2023-06-01)

Ethical concerns regarding heterologous COVID-19 vaccine administration
by: Somsri Wiwanitkit, et al.
Published: (2024-12-01)

Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women
by: Chenchit Chayachinda, et al.
Published: (2023-08-01)

Adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations
by: Amnuay Kleebayoon, et al.
Published: (2023-05-01)

Heterologous mRNA-protein vaccination with Tc24 induces a robust cellular immune response against Trypanosoma cruzi, characterized by an increased level of polyfunctional CD8+ T-cells
by: Cristina Poveda, et al.
Published: (2023-01-01)

SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines
by: Camilo C. Roa, et al.
Published: (2024-12-01)

Heterologous Prime-Boost Vaccination with Commercial FMD Vaccines Elicits a Broader Immune Response than Homologous Prime-Boost Vaccination in Pigs
by: Jaejo Kim, et al.
Published: (2023-02-01)

Perspectives in vaccines, immune response, therapeutic interventions and COVID-19
by: Irene Karampela
Published: (2023-03-01)

Heterologous Prime-Boost Immunization with DNA Vaccine and Modified Recombinant Proteins Enhances Immune Response against <i>Trueperella pyogenes</i> in Mice
by: Ting Huang, et al.
Published: (2022-05-01)

Immunogenicity and Safety of Homologous and Heterologous Prime–Boost Immunization with COVID-19 Vaccine: Systematic Review and Meta-Analysis
by: Haoyue Cheng, et al.
Published: (2022-05-01)

Immunogenicity and reactogenicity of heterologous immunization schedules with COVID-19 vaccines: a systematic review and network meta-analysis
by: Pei Li, et al.
Published: (2023-01-01)

Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients
by: Nina Körber, et al.
Published: (2023-03-01)